Convertibles Calendar: Array BioPharma to price $100 million of convertibles

JUNE 4

ARRAY BIOPHARMA INC. (Nasdaq: ARRY): $100 million of seven-year convertible senior notes; pricing after the market close Tuesday; talked to yield 3%-3.5%, up 27.5%-32.5%; registered, off the shelf; $15 million greenshoe; joint bookrunning managers Goldman Sachs & Co. and J.P. Morgan Securities LLC; non-callable for four years, then provisionally callable at 130%, with a make-whole premium based on its fundamental change make-whole table; no puts; takeover and dividend protection; proceeds to repay outstanding secured debt, with remaining proceeds for general corporate purposes; Boulder, Colo.-based biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.